9 mentions across the corpus · positive 0 · negative 8 · neutral 1 · historical 0
Daily Journal Annual Meeting 2017 — Munger Q&A
“That was really something. I probably shouldn't have done that, but you come so far, and since you're cult members you like being here, and I feel an obligation to tell you something sort of interesti”
Buffett on Trump vs. Clinton, Brexit, and Amazon's Bezos | May 2, 2016
“One of the big topics that came up and questions from shareholders was the issue. issue of Valiant. Charlie Munger made some headlines earlier this year when he really questioned their business model”
Buffett on Trump vs. Clinton, Brexit, and Amazon's Bezos | May 2, 2016
“Valiant was run. In terms of the valiant shareholders who were pushing you to take an active stake, look, there were letters released in a Wall Street Journal earlier from Bill Ackman suggesting that ”
Buffett on Trump vs. Clinton, Brexit, and Amazon's Bezos | May 2, 2016
“it was conveyed that when they bought something that was one thing for sure was the price was going to go off with the product... was absolutely certain to cause a response that was going to be catacl”
Buffett on Trump vs. Clinton, Brexit, and Amazon's Bezos | May 2, 2016
“one of them being Valiant. Charlie, you have had some very strong opinions on Valiant... You said over the weekend that Valiant was a sewer.”
Buffett on Trump vs. Clinton, Brexit, and Amazon's Bezos | May 2, 2016
“He raised a heart drug that old people really needed by 500%. And is there? It was outrageous... raising the price of an absolutely necessary drug by 500%”
Morning Session - 2016 Meeting
“We had several people who urged us strongly to buy Valiant, wanted us to meet Pearson, all that sort of thing... there were patterns at valiant that I think...should have been picked up on. And it's b”
Daily Journal Annual Meeting 2016 — Munger Q&A
“Last year, you had some very pointed comments concerning Valeant... Valeant was such an extreme example of misbehavior.”
We'll never want to "go to war" with Coca-Cola | May 5, 2014
“Bill Ackman's approach in this recent transaction between Valiant and Allergan, where he effectively teamed up with Valiant”